Evidence map›Paper›PMID 33103665›Full record

ArticleThe Analyst2020

Development of an inexpensive Raman-compatible substrate for the construction of a microarray screening platform.

Isamar Pastrana-Otero, Sayani Majumdar, Aidan E Gilchrist, Brittney L Gorman, Brendan A C Harley, Mary L Kraft

Abstract read
In one paragraph

Article in The Analyst, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Noninvasive andThe Analyst · 2025
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Isamar Pastrana-OteroDepartment of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA. mlkraft@illinois.edu.
Sayani Majumdar
Aidan E Gilchrist
Brittney L Gorman
Brendan A C Harley
Mary L Kraft

Funding

Gradient Biomaterials to Investigate Niche Regulation of HematopoiesisR01DK099528 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Brendan A. Harley · 2014 to 2026
$4.0M
Biomimetic Hydrogel Niches to Study the Malignant Phenotype of Glioblastoma MultiformeR01CA197488 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI HARLEY, BRENDAN A. · 2016 to 2020
$2.2M
Tissue microenvironment (TIMe) training programT32EB019944 · NIBIB · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI BHARGAVA, ROHIT, GASKINS, REX · 2016 to 2025
$1.9M
Label-free interrogation of heterogeneities in HSC fate decision signaturesR21EB018481 · NIBIB · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI HARLEY, BRENDAN A. · 2015 to 2016
$420k
An objective noninvasive single-cell method to identify HSC differentiation stageR21HL132642 · NHLBI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI KRAFT, MARY L · 2016 to 2017
$398k
Gradient biomaterials to investigate niche regulation of hematopoiesisR56DK099528 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI HARLEY, BRENDAN A. · 2021 to 2021
$100k
Dynamics of autocrine and paracrine signaling domains in HSC maintenanceF31DK117514 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI GILCHRIST, AIDAN · 2019 to 2020
$91k
NCI NIH HHS R01 CA197488NHLBI NIH HHS R21 HL132642NIBIB NIH HHS R21 EB018481NIBIB NIH HHS T32 EB019944NIDDK NIH HHS F31 DK117514NIDDK NIH HHS R01 DK099528NIDDK NIH HHS R56 DK099528
6 · The paper itself

Abstract

Biomaterial microarrays are being developed to facilitate identifying the extrinsic cues that elicit stem cell fate decisions to self-renew, differentiate and remain quiescent. Raman microspectroscopy, often combined with multivariate analysis techniques such as partial least square-discriminant analysis (PLS-DA), could enable the non-invasive identification of stem cell fate decisions made in response to extrinsic cues presented at specific locations on these microarrays. Because existing biomaterial microarrays are not compatible with Raman microspectroscopy, here, we develop an inexpensive substrate that is compatible with both single-cell Raman spectroscopy and the chemistries that are often used for biomaterial microarray fabrication. Standard deposition techniques were used to fabricate a custom Raman-compatible substrate that supports microarray construction. We validated that spectra from living cells on functionalized polyacrylamide (PA) gels attached to the custom Raman-compatible substrate are comparable to spectra acquired from a more expensive commercially available substrate. We also showed that the spectra acquired from individual living cells on functionalized PA gels attached to our custom substrates were of sufficient quality to enable accurate identification of cell phenotypes using PLS-DA models of the cell spectra. We demonstrated this by using cells from laboratory lines (CHO and transfected CHO cells) as well as adult stem cells that were freshly isolated from mice (long-term and short-term hematopoietic stem cells). The custom Raman-compatible substrate reported herein may be used as an inexpensive substrate for constructing biomaterial microarrays that enable the use of Raman microspectroscopy to non-invasively identify the fate decisions of stem cells in response to extrinsic cues.

Indexed as

Spectrum Analysis, RamanAnimalsCell DifferentiationCricetinaeCricetulusDiscriminant AnalysisLeast-Squares AnalysisMice

Identifiers

PMID33103665
PMCPMC7594104

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.